Sleeve gastrectomy: 5-year outcomes of a single institution
|
|
- Kathlyn Price
- 5 years ago
- Views:
Transcription
1 Surgery for Obesity and Related Diseases 9 (2013) Original article Sleeve gastrectomy: 5-year outcomes of a single institution Logan Rawlins, M.D. a, *, Melissa P. Rawlins, M.P.A., P.A.-C. b, Carey C. Brown, M.D., F.A.C.S. b, David L. Schumacher, M.D., F.A.C.S. b a Department of Surgery, Wright State University, Dayton, Ohio b Kettering Bariatric Surgery, Kettering Sycamore Hospital, Miamisburg, Ohio Received May 31, 2012; accepted August 28, 2012 Abstract Keywords: Background: Laparoscopic sleeve gastrectomy (SG) is the most recent bariatric surgical procedure to gain universal acceptance by providers and payers. Long-term clinical data on outcomes is limited at this time. Methods: We retrospectively examined 5-year outcomes (weight loss, complications, and resolution of co-morbid conditions) of patients undergoing SG at our institution. Results: Our initial SG was performed in 2005, and we operated on 55 consecutive patients who are 5 years out from surgery. Six patients were excluded from the long-term results. Four patients underwent conversion to a duodenal switch, and 2 patients died in the first year outside the perioperative period. Average starting body mass index was 65 kg/m 2. Five-year average percent excess weight loss was 86% (range 50% 103%). Percentage of co-morbidities resolved: hypertension (95%), type 2 diabetes mellitus (100%), hyperlipidemia (100%), and obstructive sleep apnea (100%). Gastroesophageal reflux disease (GERD) was resolved in 53%, and new GERD symptoms developed in 11% of patients. There was 1 staple line leak (1.9%), no strictures, no gastrointestinal bleeding, and no perioperative deaths. Conclusion: In this study, SG is a well-tolerated and effective bariatric surgical procedure with good long-term weight loss and resolution of co-morbid medical conditions. (Surg Obes Relat Dis 2013;9:21-25.) Published by Elsevier Inc. on behalf of American Society for Metabolic and Bariatric Surgery. Laparoscopic sleeve gastrectomy; Five year; Long-term; Weight loss; Outcomes; Medicare Laparoscopic sleeve gastrectomy (SG) is the most recent bariatric surgical procedure to gain universal acceptance by providers and payers. However, long-term clinical data on outcomes are limited at this time. We initially offered SG as part of a staged duodenal switch procedure for super morbidly obese patients and have since initiated SG as a stand-alone procedure secondary to promising success rates. This is consistent with other published reports of this evolution [1 3]. Controversies exist regarding surgical technique, including site of initial transection, staple cartridge choice, bougie size, staple line reinforcement, and method for intraoperative leak test [4]. SG is slow to become * Correspondence: Logan Rawlins, M.D., Kettering Sycamore Bariatric Surgery, 4000 Miamisburg Centerville Road, Suite 210, Miamisburg, OH rawlinml@yahoo.com universally covered by all insurance payers despite promising short-term outcomes. We sought to review our results of patients who were 5 years out from surgery and describe the key variations in surgical technique unique to our practice. Methods We performed a retrospective chart review of patients who underwent SG starting in 2005 and report our 5-year clinical outcomes (weight loss, complications, and resolution of co-morbid conditions). All patients consented preoperatively to the collection of data in a prospective database, which was analyzed retrospectively. The study was submitted to the hospital institutional review board for approval before analysis of data. The diagnosis of arterial hypertension was defined by a blood pressure 4120/80 mm Hg and was considered /13/$ see front matter Published by Elsevier Inc. on behalf of American Society for Metabolic and Bariatric Surgery.
2 22 L. Rawlins et al. / Surgery for Obesity and Related Diseases 9 (2013) resolved when vital signs normalized off medication. Type 2 diabetes was diagnosed by fasting blood glucose 4126 mg/dl or glycated hemoglobin 46 g/dl and requiring medication for control. Resolution was discontinuation of antiglycemic medications with these laboratory values reversed. Hyperlipidemia was defined as having a total cholesterol 4200 mg/dl, triglycerides 4150 mg/dl, or both, and was considered resolved when these values were normal without medication. The diagnosis of obstructive sleep apnea was made by a sleep study and treated with nighttime continuous positive airway pressure (CPAP). Resolution was confirmed by repeat sleep study off CPAP. Gastroesophageal reflux disease (GERD) was diagnosed by patient report. GERD was resolved if patients symptomatically tolerated withdrawal of medication 3 months after surgery. Our surgical technique started with taking down the greater curvature of the stomach and short gastric vessels with an ultrasonic dissector. An upper endoscopy was performed to rule out any gastric abnormality, and the tip of the scope was left in the first portion of the duodenum. Vertical transection of the stomach was accomplished with 5 6 firings of a 60-mm linear stapler (Ethicon Endo-Surgery, Echelon Flex, Cincinnati,OH).Thefirstfiringwasinitiated 3 cm from the pylorus, measured with a grasper. The 26.4F endoscope (8.8 mm in diameter) was used as the bougie, and each of the staple fires were taken closely against the scope, with the exception of the firing opposite to the incisura, at which the width is widened by a few unmeasured mm to prevent stenosis in this location. Three green staple loads (open staple height 4.1 mm) were used near the antrum, followed by 3 blue loads (3.5 mm) closer to the angle of His. More recently, we have added black loads (4.4 mm) and gold loads (3.8 mm); however, these products were not available in Transition between staple load sizes was determined by the operating surgeon based on intraoperative qualitative anatomical assessment of stomach thickness. No buttress material was used. A Vicryl suture was placed at each crossing staple line, and the entire staple line from the incisura to the antrum was imbricated with a running Vicryl suture. An air leak test was performed as the endoscope was withdrawn. The staple line was then covered with fibrin sealant, and a drain was left for a period of 1 week. Results We started performing SG in 2005 and have 55 patients who are 5 years out from surgery. This encompasses operating dates from January 2005 to December As of October 2011, we have performed a total of 276 SG procedures, although only patients who are 5 years out from surgery were included in this study. No patients were lost to follow-up. Six patients were excluded from the data; 4 were converted to duodenal switch at 2 years, and 2 died outside the perioperative period in the first year after surgery. One died from ischemic colitis, and the other committed suicide. Average starting body mass index Fig. 1. Sleeve gastrectomy long-term (5-year) weight loss. (BMI) was 65 kg/m 2 (range ). Five-year average weight loss results (with range) are as follows: percent excess weight loss (%EWL): 86% (range ); BMI reduction: 35 kg/m 2 (range ); percent excess BMI loss (%EBMIL): 91% (range ); percent weight loss (%WL): 53% (range ); kg lost: 95 kg (range ). Average %EWL at each yearly follow-up interval was as follows: 1 year: 56%; 2 year: 70%; 3 year: 77%; 4 year: 81% (Fig. 1). Seventy percent (n ¼ 37) of the study participants were female. Patients ages ranged from years old, with an average age of 44. Only 1 patient was 65 years or older. Fourteen of the patients were Medicare beneficiaries; the sole 65-year-old patient was one of them. There was no statistical difference in the 5-year %EWL between Medicare and non-medicare beneficiaries (84.9 versus 86.1%; P ¼.74). There was complete or near-complete resolution of comorbidities in most patients, including hypertension, type 2 diabetes mellitus, hyperlipidemia, and obstructive sleep apnea (Table 1). The only exception was GERD, which was resolved in 53% (8/15) of patients. New GERD symptoms developed in 11% (6/53) of all patients or 16% (6/38) of those without preexisting GERD. Regarding complications directly related to SG, there was 1 staple line leak (1.9%) at the angle of His, no strictures, no gastrointestinal bleeding, and no perioperative deaths. There were no conversions to an open procedure. Table 1 Sleeve gastrectomy 5-year resolution of co-morbidity Co-morbidity Resolved, % n Hypertension 95 41/43 Type 2 diabetes mellitus /19 Hyperlipidemia /23 Obstructive sleep apnea /23 Gastroesophageal reflux 53 8/15
3 Sleeve Gastrectomy: 5-Year Outcomes / Surgery for Obesity and Related Diseases 9 (2013) Discussion The most recent compilation of data regarding SG was collected and published in 2011 by Deitel et al. [5]. The mean %EWL at 5 years was 60%; however, this comprised only 4 studies with long-term data. Those studies, by Santoro [6], Weiner et al. [7], Bohdjalian et al. [8], and Himpens et al. [9], as well as those published more recently by D Hondt et al. [10], Serela et al. [11], and Strain et al. [12], are summarized in Table 2. Our cohort of patients had a much higher starting BMI compared with other published reports [5]. Initially, SG was not intended as a stand-alone procedure, but rather as a part of a staged duodenal switch for super morbidly obese patients. When patients did not require a second stage procedure after successful weight loss and resolution of comorbidities, we transitioned to performing this procedure in lower BMI patients. We have only 1 patient 465 years old included in this data. Anecdotally, we believe that older patients were more likely to have diabetes, and given that little was known on the antidiabetic effect of sleeve gastrectomy at the time, these patients were steered toward gastric bypass. As we learn more about the success of SG in diabetic patients and have an expanding group of older patients seeking bariatric surgery, we have performed this procedure more commonly in the past few years within this group. In respect to Medicare beneficiaries, most of whom were eligible based on disability instead of age, there was no difference in weight loss results compared with non-medicare beneficiaries. Our reported weight loss results are much higher than the other published data [5 12]. The reason for this is multifactorial. The most easily quantifiable variable is surgical technique. We begin our transection 3 cm from the pylorus, which is closer than many other published reports (2 8 cm) [4]. We also use a 26.4F endoscope (8.8 mm in diameter) as the bougie, creating a very tight sleeve, which is the smallest reported in the literature. We believe that this added restriction is necessary to aid the patient in modifying his or her eating habits. Other surgeons do not make the sleeve as tight because of concerns for narrowing the incisura or making the sleeve too small and developing a stricture. This has previously been reported to lead to a higher rate of leaks [13]. We have not found this to be true in our patients. Moreover, we have not had to perform dilations, stricturoplasty, or conversion to gastric bypass in any of these patients. Smaller bougie size is important to improve weight loss results and resolution of co-morbidities. This has been previously demonstrated by Atkins et al. [14], who found superior weight loss with a 40F versus 50F bougie at 4 years follow-up. In addition to surgical technique, we use other selection and management factors that we feel make a difference in weight loss, although these factors are more difficult to quantify. The patients we steer toward SG are large-volume eaters. Large-volume eaters are, theoretically, more likely to have improved weight loss with a restrictive procedure. The SG is low maintenance for these patients compared with an adjustable gastric band and has few malabsorptive effects [15]. We also use dieticians and exercise physiologists in the preoperative and postoperative management of all our patients. They are required to see these ancillary providers before surgery, in the hospital, and postoperatively at 1-week, 1-month, and 3-month intervals for the first year. They may continue to use these services at their discretion thereafter. GERD was the one co-morbidity for which there was only moderate patient improvement. Resolution occurred in only 53% (8/15) of patients, and new GERD symptoms developed in 16% (6/38) of those without preexisting GERD. This is consistent with other published reports, which have indicated that SG may be refluxogenic [6]. Mechanisms that have been postulated to account for this finding include concomitant presence of a hiatal hernia, dissection of the phrenoesophageal ligament, intact or incompetent pylorus with a narrow gastric tube, intrathoracic sleeve migration, narrowing at the incisura, or fundus regrowth ( neostomach ) [9,16 17]. Some surgeons consider a hiatal hernia or preexisting GERD to be a contraindication to SG, but we do not necessarily share that sentiment [18]. Patients with new GERD are worked up with a contrasted upper gastrointestinal series and endoscopy to rule out ulcer, stricture, sleeve migration, and Table 2 Sleeve gastrectomy 45-year weight loss literature Article Follow-up, yr n %EWL BMI (kg/m 2 ) reduction Initial BMI Weiner et al. (2007) [7] 5 8 NA Santoro (2007) [6] 5 NA 55 NA NA Himpens et al. (2010) [9] Bohdjalian et al. (2010) [8] D Hondt et al. (2011) [10] 5/6 27/23 71/56 NA 39.3 Sarela et al. (2011) [11] Strain et al. (2011) [12] Present study (2012) %EWL ¼ percent excess weight loss; BMI ¼ body mass index; NA ¼ not available.
4 24 L. Rawlins et al. / Surgery for Obesity and Related Diseases 9 (2013) neofundus. No abnormal findings were discovered in any of our patients, and they were all treated successfully with proton pump inhibitors. The single sleeve leak we experienced occurred high near the gastroesophageal junction. The leak was identified on postoperative day 3 and was treated conservatively with the drain left at the time of surgery and parenteral nutrition for 6 weeks. No stents were used. A splenic abscess was identified 1 year later and was treated with an open splenectomy. We believe this complication was related to latent infection from the leak in conjunction with splenic infarction. However, this complication presented quite late, so the true cause may be unknown. The 4 patients converted to a duodenal switch deserve some special attention. All were super-super morbidly obese (BMI: 106, 81, 76, and 73) at the time of initial surgery, and all lost significant weight before revision (BMI reduction of 34, 32, 39, and 32, respectively). At the time of revision at 2 years, the %EWL for those 4 patients was 41/55/55/68%, and at 5 years total follow-up, they settled at a %EWL of 67/ 76/92/94%, respectively. Although all 4 patients still had a BMI above 35 before conversion, only 1 had a %EWL of o50. Patients considered for conversion were those whose BMI had stabilized 435 and had persistent comorbid conditions. We did not expect patients to do so well with stand-alone SG, and our very low rate of conversion (7%) is a testament to the efficacy of this procedure as a standard bariatric operation. It may be thought that our exclusion of these 4 conversions adds bias to the study, but rather we feel the opposite, as the data are cleaner in regard to interpreting the long-term results of SG by itself. In fact, with the inclusion of those 4 patients %EWL at 5 years, the %EWL of 86% that we report did not change. In this study, we report a 100% 5-year follow-up of 49 patients after sleeve gastrectomy. This is difficult to attain. Our practice is diligent about auditing patients who do not follow-up and calling them to reestablish care. Given that this study was following only 49 specific patients 5 years out made this task somewhat easier. Of the 49, 32 had followed up with us every year for 5 years. Of the remaining 17, there was some missing data for the 4- and 5-year time points. Of the 17, 10 were still in town, and these patients were scheduled for office follow-up, their charts updated, and their data collected and recorded. The remaining 7 patients were no longer in town but were all able to be reached by phone, and their weights were based on self-reports. These 7 patients are our most unverified data, because we did not directly record it, which could be seen as a limitation of the study. Our study is further limited by its retrospective nature and small sample size. Although this data was not obtained from a prospective trial, every patient included had adequate follow-up for reporting purposes. Despite reporting 5-year outcome data on only 49 patients, this represents the largest cohort in the published literature to date. Conclusion In our experience, SG is an effective bariatric surgical procedure with good long-term (5 year) weight loss (86% EWL) and resolution of co-morbid medical conditions with a low and acceptable safety profile. Disclosure The authors have no commercial associations that might be a conflict of interest in relation to this article. References [1] Silecchia G, Rizzello M, Casella G, Fioriti M, Soricelli E, Basso N. Two-stage laparoscopic biliopancreatic diversion with duodenal switch as treatment of high-risk super-obese patients: analysis of complications. Surg Endosc 2009;23: [2] Moy J, Pomp A, Dakin G, Parikh M, Gagner M. Laparoscopic sleeve gastrectomy for morbid obesity. Am J Surg 2008;196:e56 9. [3] Iannelli A, Schneck AS, Dahman M, Negri C, Gugenhim J. Two-step laparoscopic duodenal switch for superobesity: a feasibility study. Surg Endosc 2009;23: [4] Rosenthal RJ. International Sleeve Gastrectomy Expert Panel. International Sleeve Gastrectomy Expert Panel Consensus Statement: best practice guidelines based on experience of 412,000 cases. Surg Obes Relat Dis 2012;8:8 19. [5] Deitel M, Gagner M, Erickson AL, Crosby RD. Third International Summit: current status of sleeve gastrectomy. Surg Obes Relat Dis 2011;7: [6] Santoro S. Technical aspects in sleeve gastrectomy. Obes Surg 2007; 17: [7] Weiner RA, Weiner S, Pomhoff I, Jacobi C, Makarewicz W, Weigand G. Laparoscopic sleeve Gastrectomy influence of sleeve size and resected gastric volume. Obes Surg 2007;17: [8] Bohdjalian A, Langer FB, Shakeri-Leidenmuhler S, et al. Sleeve Gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin. Obes Surg 2010;20: [9] Himpens J, Dobbeleir J, Peeters G. Longterm results of laparoscopic sleeve gastrectomy for obesity. Ann Surg 2010;252: [10] D Hondt M, Vanneste S, Pottel H, Devriendt D, Van Rooy F, Vansteenkiste F. Laparoscopic sleeve gastrectomy as a single-stage procedure for the treatment of morbid obesity and the resulting quality of life, resolution of comorbidities, food tolerance, and 6-year weight loss. Surg Endosc 2011;25: [11] Sarela AI, Dexter SP, O Kane M, Menon A, McMahon MJ. Longterm follow-up after laparoscopic sleeve gastrectomy: 8 9 -year results. Surg Obes Relat Dis 2012;8: [12] Strain GW, Saif T, Gagner M, Rossidis M, Dakin G, Pomp A. Crosssectional review of effects of laparoscopic sleeve gastrectomy at 1, 3, and 5 years. Surg Obes Relat Dis 2011;7: [13] Gagner M. Leaks after sleeve gastrectomy are associated with smaller bougies: prevention and treatment strategies. Surg Laparosc Endosc Percutan Tech 2010;20: [14] Atkins ER, Preen DB, Jarman C, Cohen LD. Improved obesity reduction and co-morbidity resolution in patients treated with 40- French bougie versus 50-French bougie four years after laparoscopic sleeve gastrectomy. Analysis of 294 patients. Obes Surg 2012;22: [15] Gehrer S, Kern B, Peters T, Christoffel-Courtin C, Peterli R. Fewer nutrient deficiencies ater laparoscopic sleeve gastrectomy (LSG) than after laparoscopic Roux-Y-gastric bypass (LRYGB) a prospective study. Obes Surg 2010;20:
5 Sleeve Gastrectomy: 5-Year Outcomes / Surgery for Obesity and Related Diseases 9 (2013) [16] Baumann T, Grueneberger J, Pache G, et al. Three-dimensional stomach analysis with computed tomography after laparoscopic sleeve gastrectomy: sleeve dilation and thoracic migration. Surg Endosc 2011;25: [17] Braghetto I, Lanzarini E, Korn O, Valladares H, Molina JC, Henriquez A. Manometric changes of the lower esophageal sphincter after sleeve Gastrectomy in obese patients. Obes Surg 2010;20: [18] Kakoulidis TP, Karringer A, Gloaguen T, Arvidsson D. Initial results with sleeve gastrectomy for patients with class I obesity (BMI kg/m2). Surg Obes Relat Dis 2009;5:425 8.
Endorsed by Executive Council June 17, American Society for Metabolic and Bariatric Surgery
Endorsed by Executive Council June 17, 2007 American Society for Metabolic and Bariatric Surgery POSITION STATEMENT ON SLEEVE GASTRECTOMY AS A BARIATRIC PROCEDURE Clinical Issues Committee Preamble. The
More informationGastric bypass vs. Sleeve gastrectomy
Gastric bypass vs. Sleeve gastrectomy SLEEVEPASS-study Sleeve gastrectomy Paulina Salminen, M.D., PhD Turku University Hospital Department of Surgery Stockholms Obesitasdagar 19.4.2012 Swedish Obese Subjects
More informationA Bariatric Patient in my Waiting Room: Choosing the Right Patient for the Right Operation: Bariatric Surgery Indications
A Bariatric Patient in my Waiting Room: Choosing the Right Patient for the Right Operation: Bariatric Surgery Indications Shahzeer Karmali MD FRCSC FACS Associate Professor Surgery University of Alberta
More informationBariatric Surgery. The Oregon Bariatric Center Surgical Team
Bariatric Surgery The Oregon Bariatric Center Surgical Team Colin MacColl, MD, Medical Director, Bariatric Surgeon Jessica Folek, MD, Bariatric Surgeon I have no disclosures Disclosures Objectives What
More informationCLINICAL RESEARCH. Emily R. Atkins & David B. Preen & Catherine Jarman & Leon D. Cohen
OBES SURG (2012) 22:97 104 DOI 10.1007/s11695-011-0493-z CLINICAL RESEARCH Improved Obesity Reduction and Co-morbidity Resolution in Patients Treated with 40-French Bougie Versus 50-French Bougie Four
More informationWeight Loss Surgery. Outline 3/30/12. What Every GI Nurse Needs to Know. Define Morbid Obesity & its Medical Consequences. Treatments for Obesity
3/30/12 Weight Loss Surgery What Every GI Nurse Needs to Know Kenneth A Cooper, D.O. March 31, 2012 Outline Define Morbid Obesity & its Medical Consequences Treatments for Obesity Bariatric (Weight-loss)
More informationLONG TERM OUTCOMES OF SLEEVE GASTRECTOMY (LSG) Jacques Himpens, Gustavo Arman The European School of Laparoscopic Surgery Brussels Belgium
LONG TERM OUTCOMES OF SLEEVE GASTRECTOMY (LSG) Jacques Himpens, Gustavo Arman The European School of Laparoscopic Surgery Brussels Belgium DISCLOSURE DR HIMPENS IS A CONSULTANT WITH ETHICON ENDOSURGERY
More informationGastric Emptying Time after Laparoscopic Sleeve Gastrectomy
International Journal of Current Research in Medical Sciences ISSN: 2454-5716 P-ISJN: A4372-3064, E -ISJN: A4372-3061 www.ijcrims.com Original Research Article Volume 4, Issue 7-2018 Gastric Emptying Time
More informationPrevalence of Barrett s Esophagus in Bariatric Patients Undergoing Sleeve Gastrectomy
OBES SURG (2016) 26:710 714 DOI 10.1007/s11695-015-1574-1 ORIGINAL CONTRIBUTIONS Prevalence of Barrett s Esophagus in Bariatric Patients Undergoing Sleeve Gastrectomy Italo Braghetto Attila Csendes Published
More informationAhmed Abdelwahab Nafady [5] Affiliation(s) IJSER. professor of general surgery, Beni-Suef University.
International Journal of Scientific & Engineering Research Volume 9, Issue 10, October-2018 1305 laparoscopic Sleeve Gastrectomy assessment of different operative techniques Author(s): Ahmed Mohammed Abdel
More informationLaparoscopic Sleeve Gastrectomy: Symptoms of Gastroesophageal Reflux can be Reduced by Changes in Surgical Technique
OBES SURG (2012) 22:1874 1879 DOI 10.1007/s11695-012-0746-5 CLINICAL RESEARCH Laparoscopic Sleeve Gastrectomy: Symptoms of Gastroesophageal Reflux can be Reduced by Changes in Surgical Technique Jorge
More informationLong-Term Outcomes of Laparoscopic Sleeve Gastrectomy a Single-Center, Retrospective Study
DOI 10.1007/s11695-017-2795-2 ORIGINAL CONTRIBUTIONS Long-Term Outcomes of Laparoscopic Sleeve Gastrectomy a Single-Center, Retrospective Study Piotr K. Kowalewski 1 & Robert Olszewski 2,3 & Maciej S.
More informationSurgical management of super super obese patients: Roux-en-Y gastric bypass versus sleeve gastrectomy
Surg Endosc (2016) 30:2097 2102 DOI 10.1007/s00464-015-4465-6 and Other Interventional Techniques Surgical management of super super obese patients: Roux-en-Y gastric bypass versus sleeve gastrectomy Raquel
More informationADVANCE AT YOUR OWN PACE
ADVANCE AT YOUR OWN PACE Welcome and Introductions Obesity and Its Impact on Health Surgeon Introduction Surgical Weight Loss Options AGENDA OSVALDO ANEZ, MD 28 years of experience Performed approximately
More information7th International Congress of the Spanish Society of Obesity Surgery. Valladolid Spain May, 2004.
7th International Congress of the Spanish Society of Obesity Surgery. Valladolid Spain May, 2004. DIMINISHING POSTOPERATIVE RISKS OF GASTRIC BYPASS Stenosis Stenosis Leak Leak Bleeding Bleeding Stenosis
More informationSleeve Gastrectomy: Harmful. John C. Eun, PGY-5 General Surgery Grand Rounds University of Colorado Denver 11/22/10
Sleeve Gastrectomy: Harmful John C. Eun, PGY-5 General Surgery Grand Rounds University of Colorado Denver 11/22/10 Background Obesity: Body Mass Index >30 Risk factor for CAD, DM, Cancers Obesity Trends*
More informationTechnique. Matthew Bettendorf, MD Essentia Health Duluth Clinic. Laparoscopic approach One 12mm port, Four 5mm ports
Matthew Bettendorf, MD Essentia Health Duluth Clinic Technique Laparoscopic approach One 12mm port, Four 5mm ports Single staple line with no anastamosis 85% gastrectomy Goal to remove
More informationViriato Fiallo, MD Ursula McMillian, MD
Viriato Fiallo, MD Ursula McMillian, MD Objectives Define obesity and effects on society and healthcare Define bariatric surgery Discuss recent medical management versus surgery research Evaluate different
More informationOutcome of over-sewing reinforcement of gastric staple line during laparoscopic sleeve gastrectomy in morbid obese patients: single center experience
International Surgery Journal Abdallah AM. Int Surg J. 2018 Mar;5(3):991-996 http://www.ijsurgery.com pissn 2349-3305 eissn 2349-2902 Original Research Article DOI: http://dx.doi.org/10.18203/2349-2902.isj20180818
More informationSURGICAL MANAGEMENT OF OBESITY. Anne Lidor, MD, MPH Professor of Surgery Chief, Division of Minimally Invasive and Bariatric Surgery
SURGICAL MANAGEMENT OF OBESITY Anne Lidor, MD, MPH Professor of Surgery Chief, Division of Minimally Invasive and Bariatric Surgery Multi-Factorial Causes of Morbid Obesity include: Genetic Environmental
More informationPolicy Specific Section: April 14, 1970 June 28, 2013
Medical Policy Bariatric Surgery Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Surgery Original Policy Date: Effective Date: April 14, 1970 June 28, 2013 Definitions
More informationLSG and intractable GERD: how to prevent? How to treat? Jacques M Himpens, the European School of Laparoscopic Surgery, Brussels, Belgium
LSG and intractable GERD: how to prevent? How to treat? Jacques M Himpens, the European School of Laparoscopic Surgery, Brussels, Belgium Jacques Himpens is a consultant with Ethicon Endosurgery and With
More informationBariatric Surgery: How complex is this? Pradeep Pallati, MD, FACS, FASMBS
Bariatric Surgery: How complex is this? Pradeep Pallati, MD, FACS, FASMBS Nothing to Disclose Types of Bariatric Surgery Restrictive Malabsorptive Combination Restrictive and Malabsorptive Newer Endoluminal
More informationBenefits of Bariatric Surgery
Benefits of Bariatric Surgery Dr Tan Bo Chuan Registrar, Department of Surgery GP Forum 27 May 2017 Improvements of Co-morbidities Type 2 diabetes mellitus Hypertension Hyperlipidemia Degenerative joint
More informationBariatric Surgery: Indications and Ethical Concerns
Bariatric Surgery: Indications and Ethical Concerns Ramzi Alami, M.D. F.A.C.S Assistant Professor of Surgery American University of Beirut Medical Center Beirut, Lebanon Nothing to Disclose Determined
More informationThe Surgical Management of Obesity
The Surgical Management of Obesity Omar al noubani MD,MRCS وك ل وا و اش ز ب وا و ال ت س رف وا األعراف ما مأل ابن آدم وعاء شر ا من بطنه Persons who are naturally fat are apt to die earlier than those who
More informationHere are some types of gastric bypass surgery:
Gastric Bypass- Definition By Mayo Clinic staff Weight-loss (bariatric) surgeries change your digestive system, often limiting the amount of food you can eat. These surgeries help you lose weight and can
More informationANZMOSS 2018 Melbourne Bariatric Surgery Masterclass
ANZMOSS 2018 Melbourne Bariatric Surgery Masterclass WHICH OPERATION TO CHOOSE ANTHONY CLOUGH The options SURGICAL OPTIONS? - A MINEFIELD An explosion of operative variants Local technical variations Local
More informationSurgical Treatment of Obesity. 1. Understand who is an appropriate candidate for referral for surgical weight loss.
Surgical Treatment of Obesity Learning Objectives: 1. Understand who is an appropriate candidate for referral for surgical weight loss. 2. Appreciate impact of operative weight reduction to improve co-morbid
More informationDisclosure. consultant to Ethicon Endosurgery. case mix disclosure. LRYGB sleeve BPD revisions OAGB ( minibp ), SADI: 0% 19% 55% 23%
Disclosure consultant to Ethicon Endosurgery case mix disclosure 3% 19% 23% 55% LRYGB sleeve BPD revisions OAGB ( minibp ), SADI: 0% Disclosure consultant to Ethicon Endosurgery case mix disclosure 3%
More informationLong term laparoscopic Sleeve gastrectomy outcomes
Long term laparoscopic Sleeve gastrectomy outcomes Gerhard Prager Department of General Surgery Metabolic and Bariatric Surgery Long-term results of gastric sleeve resection / Gerhard Prager Metabolic
More informationMorbid Obesity A Curable Disease?
Morbid Obesity A Curable Disease? Piotr Gorecki, M.D. F.A.C.S. Associate Professor of Clinical Surgery Weill Medical College of Cornell University Chief of Laparoscopic Surgery New York Methodist Hospital
More informationSurgical Therapy for Morbid Obesity. Janeen Jordan, PGY 5 Surgical Grand Rounds April 7, 2008
Surgical Therapy for Morbid Obesity Janeen Jordan, PGY 5 Surgical Grand Rounds April 7, 28 Obesity BMI > 3 kg/m 2 Moderate 35-4 kg/m 2 Morbid >4 kg/m 2 1.7 BILLION Overweight Adults in the world 63 MILLION
More informationAmerican Society for Metabolic & Bariatric Surgery
American Society for Metabolic & Bariatric Surgery April 27, 2012 Louis Jacques, MD Director, Coverage and Analysis Group Centers for Medicare and Medicaid Services Mail Stop S3-02-01 7500 Security Boulevard
More informationIndian Journal of Medical Research and Pharmaceutical Sciences July 2017;4(7) ISSN: ISSN: DOI: /zenodo Impact Factor: 3.
GALLBLADDER DISEASES ASSOCIATED WITH LAPAROSCOPIC SLEEVE GASTRECTOMY IN JORDAN, PILOT STUDY Dr. Osama T. Abu Salem*, Dr. Ibrahim Al Gwairy, Dr. Ramadan Al Hasanat & Dr. Talal Jalabneh** *Consultant Gneral
More information6/23/2011. Bariatric Surgery: What the Primary Care Provider Should Know. Case Presentation: Rachelle
Bariatric Surgery: What the Primary Care Provider Should Know 2,000 B.C. 2,000 A.D. Case Presentation: Rachelle 35 year-old woman with morbid obesity. 5 1 236 lbs BMI 44.5 PMHx: mild depression obstructive
More informationCommonly Performed Bariatric Procedures in Singapore. Lin Jinlin Associate Consultant General, Upper GI and Bariatric Surgery Changi General Hospital
Commonly Performed Bariatric Procedures in Singapore Lin Jinlin Associate Consultant General, Upper GI and Bariatric Surgery Changi General Hospital Scope 1. Introduction 2. Principles of bariatric surgery
More informationDisclosures. Obesity and Its Challenges: Outline. Outline 5/2/2013. Lan Vu, MD Division of Pediatric Surgery Department of Surgery
Obesity and Its Challenges: Bariatric Surgery: Why or Why Not I have nothing to disclose Disclosures Lan Vu, MD Division of Pediatric Surgery Department of Surgery Outline Growing obesity epidemic Not
More informationMedium-Term Results of Laparoscopic Sleeve Gastrectomy: a Matched Comparison with Gastric Bypass
DOI 10.1007/s11695-015-1582-1 ORIGINAL CONTRIBUTIONS Medium-Term Results of Laparoscopic Sleeve Gastrectomy: a Matched Comparison with Gastric Bypass Wei-Jei Lee & Eng-Hong Pok & Abdullah Almulaifi & Ju
More informationEffect of Pyloric Balloon Dilatation on GERD after LSG
Med. J. Cairo Univ., Vol. 83, No. 1, December: 171-177, 215 www.medicaljournalofcairouniversity.net Effect of Pyloric Balloon Dilatation on GERD after LSG AHMAD Y.I. ABD EL-DAYEM, M.Sc.; MOHAMMAD E. EL-QOUSY,
More informationBariatric Care Center Outcomes Report
Bariatric Care Center 215 Outcomes Report Since my surgery, my life is happier; I am happier with myself. Lisa Mark, Weight Loss Surgery Patient 2 Bariatric Care Center Contents Surgical Procedure Volume
More informationName of. Date sent. The article. correlation CONCLUSION. polishing. Google Search: [ ] High priority for. publication [ ] Plagiarism
Reviewer s code: 00503618 Reviewer s country: United States Date reviewed: 2016-09-05 09:21 [ ] Grade A: Priority publishing [ ] Grade B: Very good [ Y] Grade B: Minor language [ Y] Grade C: Good [ ] Grade
More informationBariatric surgery: Impact on Co-morbidities and Weight Loss Expectations ALIYAH KANJI, MD FRCSC MIS AND BARIATRIC SURGERY SEPTEMBER 22, 2018
Bariatric surgery: Impact on Co-morbidities and Weight Loss Expectations ALIYAH KANJI, MD FRCSC MIS AND BARIATRIC SURGERY SEPTEMBER 22, 2018 Disclosures None Objectives Review expected weight loss from
More informationCLINICAL REPORT. Evangelos Menenakos & Konstantinos M. Stamou & Konstantinos Albanopoulos & Joanna Papailiou & Demetrios Theodorou & Emmanuel Leandros
OBES SURG (2010) 20:276 282 DOI 10.1007/s11695-009-9918-3 CLINICAL REPORT Laparoscopic Sleeve Gastrectomy Performed with Intent to Treat Morbid Obesity: A Prospective Single-Center Study of 261 Patients
More informationSupplementary Online Content
Supplementary Online Content Peterli R, Wölnerhanssen BK, Peters T, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity:
More informationMedicare Part C Medical Coverage Policy
Morbid Obesity Surgery Origination: June 30, 1988 Review Date: October 18, 2017 Next Review: October, 2019 Medicare Part C Medical Coverage Policy DESCRIPTION OF PROCEDURE OR SERVICE Bariatric surgery
More informationOBESITY MANAGEMENT: DIET/EXERCISE, NEW DRUGS AND/OR SURGERY?
OBESITY MANAGEMENT: DIET/EXERCISE, NEW DRUGS AND/OR SURGERY? ERIC VOLCKMANN, MD DIRECTOR OF BARIATRIC SURGERY OCTOBER 20, 2017 OBJECTIVES Define prevalence and health effects of obesity Discuss different
More informationIntroduction ORIGINAL CONTRIBUTIONS
DOI 10.1007/s11695-017-2569-x ORIGINAL CONTRIBUTIONS Case-Control Study of Postoperative Blood Pressure in Patients with Hemorrhagic Complications after Laparoscopic Sleeve Gastrectomy and Matched Controls
More informationResearch Article Laparoscopic Gastric Sleeve and Micronutrients Supplementation: Our Experience
Obesity Volume 2012, Article ID 672162, 5 pages doi:10.1155/2012/672162 Research Article Laparoscopic Gastric Sleeve and Micronutrients Supplementation: Our Experience D. Capoccia, 1 F. Coccia, 1 F. Paradiso,
More informationBariatric Surgery: The Primary Care Approach
The 8 th Annual Conference of the Lebanese Society of Family Medicine October 25 th 2009 Bariatric Surgery: The Primary Care Approach Bassem Y. Safadi, MD, FACS Associate Professor of Clinical Surgery
More informationAn Overview of the Effects of Various types of Bariatric Surgical Operations in the Azerbaijani Population
Research Article An Overview of the Effects of Various types of Bariatric Surgical Operations in the Azerbaijani Population Omarov TI 1,2*, Salimova Elvina 2, Samedov EN 1, Zeynalov NA 1, Bayramov NY 1
More informationOverview. Stanley J. Rogers, MD, FACS Associate Clinical Professor of Surgery University of California San Francisco
GASTROINTESTINAL COMPLICATIONS AFTER BARIATRIC SURGERY Stanley J. Rogers, MD, FACS Associate Clinical Professor of Surgery University of California San Francisco UCSF DEPARTMENT OF SURGERY Original Article
More informationBariatric Surgery. Overview of Procedural Options
Bariatric Surgery Overview of Procedural Options The Obesity Epidemic In 1991, NO state had an obesity rate above 20% 1 As of 2010, more than two-thirds of states (38) now have adult obesity rates above
More informationCurrent Status of Bariatric Surgery in Asia
Emerald hall A, 1:2-1:5, November 7, 213 Current Status of Bariatric Surgery in Asia Go Wakabayashi, MD, PhD, FACS Professor and Chairman Department of Surgery Iwate Medical University Numbers of bariatric
More informationChoice Critria in Bariatric Surgery. Giovanni Camerini
Choice Critria in Bariatric Surgery Giovanni Camerini Surgical vs Medical treatment Indications for Bariatric Surgery (WHO 1992) BMI of at least 40; BMI of 35 in case of serious diseases related to obesity;
More informationJianzhong Di 1,2, Chen Wang 1, Pin Zhang 1, Xiaodong Han 1, Weijie Liu 1, Hongwei Zhang 1. Introduction
Original Article Page 1 of 8 The middle-term result of laparoscopic sleeve gastrectomy in Chinese obesity patients in a single hospital, with the review of literatures and strategy for gastric stenosis
More informationThe Clinical Effect of Laparoscopic Sleeve Gastrectomy And Complications
International Journal of Medical Research and Applications Volume 1, Issue 1, (Jan-Feb 2017), PP 01-07 The Clinical Effect of Laparoscopic Sleeve Gastrectomy And Complications Warda Mohayuddin, Samiullah,
More informationSURGICAL TREATMENT FOR OBESITY: WHAT S THE BEST OPTION? Natan Zundel, MD, FACS, FASMBS
SURGICAL TREATMENT FOR OBESITY: WHAT S THE BEST OPTION? Natan Zundel, MD, FACS, FASMBS Professor of Surgery Vice-Chairman Department of Surgery Florida International University Herbert Wertheim College
More informationSingle Anastomosis Gastric Bypass Comparative Short-Term Outcome Study of Conversional and Primary Procedures
DOI 10.1007/s11695-016-2336-4 ORIGINAL CONTRIBUTIONS Single Anastomosis Gastric Bypass Comparative Short-Term Outcome Study of Conversional and Primary Procedures Chanan Meydan 1,2 & Asnat Raziel 1 & Nasser
More informationThe Impact of Pyloric Pouch Size (3 cm and 6 cm) in Sleeve Gastrectomy on Postoperative Reflux and Vomiting
Med. J. Cairo Univ., Vol. 83, No. 2, September: 119-125, 2015 www.medicaljournalofcairouniversity.net The Impact of Pyloric Pouch Size (3 cm and 6 cm) in Sleeve Gastrectomy on Postoperative Reflux and
More informationIs laparoscopic sleeve gastrectomy safer than laparoscopic gastric bypass?
Is laparoscopic sleeve gastrectomy safer than laparoscopic gastric bypass? A comparison of 30-day complications using the MBSAQIP data registry Sandhya B. Kumar MD, Barbara C. Hamilton MD, Soren Jonzzon,
More informationMBSAQIP Complex Clinical Scenarios & Variable Review
MBSAQIP Complex Clinical Scenarios & Variable Review Disclosure The following planners, speakers, moderators, and/or panelists of the CME/CEU activity have no relevant financial relationships with commercial
More informationBariatric Surgery Corporate Medical Policy
Bariatric Surgery Corporate Medical Policy File name: Bariatric Surgery File code: UM.SURG.01 Origination: 07/2008 Last Review: 06/2018 Next Review: 06/2019 Effective Date: 10/01/2018 Description/Summary
More informationCurrent Trends in Bariatric Surgery
Current Trends in Bariatric Surgery 9.28.2017 Abraham Krikhely, MD, FACS, FASMBS Assistant Professor of Surgery, CUMC Center of Minimal Access, Metabolic and Weight Loss Surgery Outline Why consider surgery
More informationNot over when the surgery is done: surgical complications of obesity
Not over when the surgery is done: surgical complications of obesity Gianluca Bonanomi, MD, FRCS Consultant Surgeon and Honorary Senior Lecturer Chelsea and Westminster Hospital London The Society for
More informationThe case for reductive surgery: a more efficient and cost-effective option
Emil Loots MBChB (Pret), FCS (SA) Cert Gastro (SA) Surg PhD Candidate The case for reductive surgery: a more efficient and cost-effective option Big day in Pretoria Controversies Controversy around the
More informationAdipocytes, Obesity, Bariatric Surgery and its Complications
Adipocytes, Obesity, Bariatric Surgery and its Complications Daniel C. Morris, MD, FACEP, FAHA Senior Staff Physician Department of Emergency Medicine Objectives Basic science of adipocyte Adipocyte tissue
More information11/11/2011. Bariatric Surgery for Sleep Apnea. Case Presentation: Rachelle. Case Presentation: Rachelle. Case Presentation: Rachelle
Bariatric Surgery for Sleep Apnea 2,000 B.C. 2,000 A.D. 35 year-old woman with morbid obesity. 5 1 236 lbs BMI 44.5 PMHx: mild depression obstructive sleep apnea (AHI 42, on CPAP) asthma polycystic ovarian
More informationThe Bariatric and Heartburn Center of Northeast Ohio
The Bariatric and Heartburn Center of Northeast Ohio A message from Dr. Chlysta: Walter J. Chlysta MD, FACS, FASMBS 1900 23 rd Street, Suite 403 Cuyahoga Falls, OH 44223 Phone 330-926-3443 Fax 330-255-5092
More informationBariatric Surgery Update
Bariatric Surgery Update Alexander Perez, MD, FACS Professor of Surgery Chief, Division Minimally Invasive and Foregut Surgery Speaker Disclosure Dr. Perez has disclosed that the has no actual or potential
More informationBariatric Surgery MM /11/2001. HMO; PPO; QUEST 05/01/2012 Section: Surgery Place(s) of Service: Outpatient; Inpatient
Bariatric Surgery Policy Number: Original Effective Date: MM.06.003 09/11/2001 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST 05/01/2012 Section: Surgery Place(s) of Service: Outpatient;
More informationSOUND HEALTH & WELLNESS TRUST
WEIGHT LOSS SURGERY POLICY SOUNDPLUS PPO AND SOUND PPO PLANS All procedures approved by the Plan must be pre-authorized by Aetna (the Trust s Utilization Management Vendor) and care must be provided by
More informationGastrointestinal Surgery for Severe Obesity 2.0 Contact Hours Presented by: CEU Professor
Gastrointestinal Surgery for Severe Obesity 2.0 Contact Hours Presented by: CEU Professor 7 www.ceuprofessoronline.com Copyright 8 2007 The Magellan Group, LLC All Rights Reserved. Reproduction and distribution
More informationDISCLOSURES. Laparoscopic Adjustable Gastric Banding (LAGB) As An Option For Failed Gastric Bypass Procedure In Obese Patients
Laparoscopic Adjustable Gastric Banding (LAGB) As An Option For Failed Gastric Bypass Procedure In Obese Patients Presented By: Ali Hazrati, Md, Msc, FRCSC Co-authors: Patrick Yau, MD, Jamie Cyriac, MD
More informationChapter 4 Section 13.2
TRICARE Policy Manual 6010.60-M, April 1, 2015 Surgery Chapter 4 Section 13.2 Issue Date: November 9, 1982 Authority: 32 CFR 199.2(b) and 32 CFR 199.4(e)(15) Copyright: CPT only 2006 American Medical Association
More informationThe Egyptian Journal of Hospital Medicine (January 2019) Vol. 74 (3), Page
The Egyptian Journal of Hospital Medicine (January 2019) Vol. 74 (3), Page 504-510 Comparative between the Complications of Sleeve Gastrectomy versus the Complications of Gastric Bypass Mohamed Fathy Sharaf,
More informationRole of Malabsorptive Endoscopic Procedures in Obesity Treatment
FOCUSED REVIEW SERIES: Roles of Bariatric Endoscopy in Obesity Treatment Clin Endosc 2017;50:26-30 https://doi.org/10.5946/ce.2017.004 Print ISSN 2234-2400 On-line ISSN 2234-2443 Open Access Role of Malabsorptive
More informationENTRY CRITERIA: C. Approved Comorbidities: Diabetes
KAISER PERMANENTE OHIO BARIATRIC SURGERY (GASTROPLASTY) Methodology: Expert Opinion Issue Date: 12-05 Champion: Surgery Review Date: 4-10, 4-12 Key Stakeholders: Surgery, IM Depts. Next Update: 4-14 RELEVANCE:
More informationComparison Between Laparoscopic Sleeve Gastrectomy and Laparoscopic Adjustable Gastric Banding for Morbid Obesity: a Meta-analysis
OBES SURG (2013) 23:980 986 DOI 10.1007/s11695-013-0893-3 REVIEW Comparison Between Laparoscopic Sleeve Gastrectomy and Laparoscopic Adjustable Gastric Banding for Morbid Obesity: a Meta-analysis Sen Wang
More informationLecture Goals. Body Mass Index. Obesity Definitions. Bariatric Surgery What the PCP Needs to Know 11/17/2009. Indications for bariatric Surgeries
Bariatric Surgery What the PCP Needs to Know Mouna Abouamara Assistant Professor Internal Medicine James H Quillen College Of Medicine Lecture Goals Indications for bariatric Surgeries Different types
More informationTechnical Controversies in Laparoscopic Sleeve Gastrectomy
OBES SURG (2012) 22:182 187 DOI 10.1007/s11695-011-0492-0 REVIEW Technical Controversies in Laparoscopic Sleeve Gastrectomy Manuel Ferrer-Márquez & Ricardo Belda-Lozano & Manuel Ferrer-Ayza Published online:
More informationWeight Loss and Comorbidity Resolution 3 Years After Bariatric Surgery an Indian Perspective
Weight Loss and Comorbidity Resolution 3 Years After Bariatric Surgery an Indian Perspective Amrit Manik Nasta, Ramen Goel, Shefali Dharia, Madhu Goel & Shireen Hamrapurkar Obesity Surgery The Journal
More informationBariatric Surgery Outcomes
Bariatric Surgery Outcomes Kristoffel R. Dumon, MD a, Kenric M. Murayama, MD b, * KEYWORDS Bariatric surgery Outcomes Obesity Obesity is a global health problem and the exponential increase in obesity
More informationReoperation Bariatric Surgery:
Reoperative Bariatric Surgery, Achieving Insurance Authorization Achieving insurance authorization for reoperative bariatric procedures is not difficult provided that prior insurance company authorization
More informationNOTE: This policy is not effective until May 1, To view the current policy, click here. IMPORTANT REMINDER
NOTE: This policy is not effective until May 1, 2018. To view the current policy, click here. Medical Policy Manual Surgery, Policy No. 58 Bariatric Surgery Next Review: December 2018 Last Review: January
More informationLife Science Journal 2018;15(4)
Short-term outcome of laparoscopic sleeve gastrectomy (LSG) and laparoscopic gastric plication (LGP) in morbidly obese patients Islam M. Ibrahim MD., Abd Elrahman Metwalli MD and Tamer Rushdy MD. General
More informationAssociate. Professor of. Minimally. Invasive Surgery
Surgical Task Force Recommendations Ken Reed MD, FRSCS Committee Chair, and Staff Surgeon, Guelph General Hospital Clinical Associate Professor of Surgery, McMaster University Dennis Hong MD, MS.c, FRCSC,
More informationPerioperative complications in a consecutive series of 1000 duodenal switches
Surgery for Obesity and Related Diseases 9 (2013) 63 68 Original article Perioperative complications in a consecutive series of 1000 duodenal switches Laurent Biertho, M.D. a, *, Stéfane Lebel, M.D. a,
More informationSleeve Gastrectomy for Morbid Obesity: Robotic vs Standard Laparoscopic Sleeve Gastrectomy Methods
WJOLS Sleeve Gastrectomy for Morbid Obesity: Robotic vs Standard Laparoscopic 10.5005/jp-journals-10033-1209 Sleeve Gastrectomy Methods original article Sleeve Gastrectomy for Morbid Obesity: Robotic vs
More informationReconstruction of leaking gastric pouch after redo Rouxen-Y gastric bypass revisionary surgery strategy
Original paper Videosurgery Reconstruction of leaking gastric pouch after redo Rouxen-Y gastric bypass revisionary surgery strategy Wojciech K. Karcz 1, Cheng Zhou 2, William Braun 3, Piotr Małczak 4,
More informationWelche Operation für welchen Patienten: Sleeve, Bypass oder?
Welche Operation für welchen Patienten: Sleeve, Bypass oder?? Prof. Dr. med. Ralph Peterli Stv. Chefarzt Clarunis Leiter Forschungsplattform Viszeralchirurgie und bariatrisches Referenzzentrum Präsident
More informationGoals 1/9/2018. Obesity over the last decade Surgery has become a safer management strategy Surgical options for management
The Current State of Surgical Intervention in Management of Morbid Obesity Goals Obesity over the last decade Surgery has become a safer management strategy Surgical options for management 1 Goals Obesity
More informationLaparoscopic Sleeve Gastrectomy in Patients With Preexisting Gastroesophageal Reflux Disease A National Analysis
Research Original Investigation PACIFIC COAST SURGICAL ASSOCIATION Laparoscopic Sleeve Gastrectomy in Patients With Preexisting Gastroesophageal Reflux Disease A National Analysis Cecily E. DuPree, DO;
More informationMEDICAL COVERAGE POLICY. SERVICE: Bariatric (Weight Loss) Surgery Policy Number: 053 Effective Date: 08/01/2017 Last Review: 05/16/2017
Important note Even though this policy may indicate that a particular service or supply is considered covered, this conclusion is not necessarily based upon the terms of your particular benefit plan. Each
More informationSLEEVEPASS RCT: SLEEVE vs. bypass 5-year results
SLEEVEPASS RCT: SLEEVE vs. bypass 5-year results Thun 30.11.2018 Paulina Salminen MD, PhD, Professor of Surgery Turku University Hospital, Turku, Finland SLEEVEPASS trial PI Disclosures Lecture fees: Merck,
More informationGastric bypass is safe and effective for the super-super-obese patient
Original Article Page 1 of 6 Gastric bypass is safe and effective for the super-super-obese patient Vadim Meytes, Grace C. Chang, Mazen Iskandar, George Ferzli NYU Lutheran Medical Center, Brooklyn, NY,
More informationSession 6B Appropriate Treatment of Obesity Demonstrates Clinical & Economic Success
Session 6B Appropriate Treatment of Obesity Demonstrates Clinical & Economic Success Part 2 John Dawson, FSA, MAAA Appropriate Treatment of Obesity Demonstrates Clinical & Economic Success SOA Asia-Pacific
More information3 Things To Know About Obesity Surgery
3 Things To Know About Obesity Surgery Dr Jon Armstrong 1st Edition Introduction... 3 1. Am I A Candidate?... 4 2. What Are The Options?... 5 3. How Does It Work?... 6 Conclusion... 9 Follow me here...
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,500 108,000 1.7 M Open access books available International authors and editors Downloads Our
More informationOG Tube/Bougie vs. Suction Calibration System for Effects on Operative Duration, Staple-line Corkscrewing, and Esophageal Perforation during LSG.
July 14, 2015 OG Tube/Bougie vs. Suction Calibration System for Effects on Operative Duration, Staple-line Corkscrewing, and Esophageal Perforation during LSG. Michel Gagner, MD, FRCSC, FACS, FASMBS Rose
More information